GAMMA Investing »

Vir Biotechnology shares owned by GAMMA Investing

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $27k 2.7k 10.13
2023-12-31 $7.3k 774 9.40

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Vir Biotechnology

Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Bill & Melinda Gates Foundation
Bank of New York Mellon
D. E. Shaw & Co
Charles Schwab Investment Management
Goldman Sachs Group
Voloridge Investment Management
UBS Group
Dimensional Fund Advisors
Principal Financial Group
Barclays
Millennium Management

View all funds holding Vir Biotechnology